<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM: To investigate the <z:mpath ids='MPATH_177'>angiogenesis</z:mpath>-related protein expression profile characterizing <z:e sem="disease" ids="C0948380" disease_type="Neoplastic Process" abbrv="">metastatic colorectal cancer</z:e> (mCRC) with the aim of identifying prognostic markers </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: The expression of 44 <z:mpath ids='MPATH_177'>angiogenesis</z:mpath>-secreted factors was measured by a novel cytokine antibody array methodology </plain></SENT>
<SENT sid="2" pm="."><plain>The study evaluated vascular endothelial growth factor (VEGF) and its soluble vascular endothelial growth factor receptor (sVEGFR)-1 protein levels by enzyme immunoassay (EIA) in a panel of 16 CRC cell lines </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="2" ids="33699">mRNA</z:chebi> VEGF and VEGF-A isoforms were quantified by quantitative reverse-transcription polymerase chain reaction (Q-RT-PCR) and vascular endothelial growth factor receptor (VEGFR)-2 expression was analyzed by flow cytometry </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">Metastasis</z:e>-derived <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cell lines expressed a distinctive molecular profile as compared with those isolated from a <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumor</z:e> site </plain></SENT>
<SENT sid="5" pm="."><plain>Metastatic <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cell lines were characterized by higher expression of angiogenin-2 (Ang-2), macrophage chemoattractant proteins-3/4 (<z:chebi fb="17" ids="50099">MCP</z:chebi>-3/4), matrix metalloproteinase-1 (MMP-1), and the chemokines interferon γ inducible T cell α chemoattractant protein (I-<z:chebi fb="44" ids="53498">TAC</z:chebi>), monocyte chemoattractant protein I-309, and interleukins interleukin (IL)-2 and IL-1α, as compared to <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumor</z:e> cell lines </plain></SENT>
<SENT sid="6" pm="."><plain>In contrast, primary <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cell lines expressed higher levels of interferon γ (IFN-γ), insulin-like growth factor-1 (IGF-1), IL-6, leptin, epidermal growth factor (EGF), placental growth factor (PlGF), thrombopoietin, transforming growth factor β1 (TGF-β1) and VEGF-D, as compared with the metastatic cell lines </plain></SENT>
<SENT sid="7" pm="."><plain>VEGF expression does not significantly differ according to the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cellular origin in normoxia </plain></SENT>
<SENT sid="8" pm="."><plain>Severe <z:mp ids='MP_0005039'>hypoxia</z:mp> induced VEGF expression up-regulation but contrary to expectations, metastatic <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cell lines did not respond as much as primary cell lines to the hypoxic stimulus </plain></SENT>
<SENT sid="9" pm="."><plain>In <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> primary-derived cell lines, we observed a two-fold increase in VEGF expression between normoxia and <z:mp ids='MP_0005039'>hypoxia</z:mp> as compared to metastatic cell lines </plain></SENT>
<SENT sid="10" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cell lines express a similar pattern of VEGF isoforms (VEGF₁₂₁, VEGF₁₆₅ and VEGF₁₈₉) despite variability in VEGF expression, where the major transcript was VEGF₁₂₁ </plain></SENT>
<SENT sid="11" pm="."><plain>No relevant expression of VEGFR-2 was found in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cell lines, as compared to that of human umbilical vein endothelial cells and sVEGFR-1 expression did not depend on the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cellular origin </plain></SENT>
<SENT sid="12" pm="."><plain>CONCLUSION: A distinct <z:mpath ids='MPATH_177'>angiogenesis</z:mpath>-related expression pattern characterizes metastatic <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cell lines </plain></SENT>
<SENT sid="13" pm="."><plain>Factors other than VEGF appear as prognostic markers and intervention targets in the metastatic <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> setting </plain></SENT>
</text></document>